• Definium Therapeutics issued inducement stock options covering 56,650 common shares to three newly hired non-executive employees.
• Grants carry an effective date of Sept. 14, 2026.
• Exercise price set at the closing price of the common shares on the grant date.
• Vesting runs four years with 25% after year one, then monthly vesting for the remaining 75% over three years.
• Awards were issued under the company’s 2026 Inducement Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609140600BIZWIRE_USPR_____20260914_BW552575) on September 14, 2026, and is solely responsible for the information contained therein.